This week's blog is written by Lorraine Gambacourt, RDH:
As always, In the month of February we are reminded of a staggering statistic: Heart disease is the leading cause of death in Canada, and globally.
This highly preventable disease is posing a strain on our health care system and decreasing the length and quality of the lives of those we care about.
I am sure that you as well as I, have lost friends or family members in their 40’s and 50’s as a result of a heart attack or stroke. Most oral health professionals (especially those who are aware of the Bale/Doneen Method) also now understand that people with gum disease are 50% more likely to suffer a heart attack or stroke. This is yet another staggering statistic that we, as health care professionals have the ability to impact and reduce the potential for.
How do we accomplish this daunting task?
Focusing on these three points will make a difference:
Let’s look at our task a little more in depth using the analogy of a football game. We, the dental health professionals are the home team. The pathogenic biofilm is the away team. And of course, we want to win!
1) Know and evaluate your opponents. You’ve heard the expression: “Keep your friends close, and your enemies closer.” We want to know about the team we are playing so we can understand their strengths and weakness. What is the playing field like? Who are the players and the biggest influencers?
Using BiofilmDNA™ as part of our risk analysis will help us understand what we are dealing with before we assist our clients on their journey from disease to improved oral health and decreased systemic risk. What high and moderate risk pathogens are present and what are their numbers? Are Pg and Aa present at high levels increasing the potential for biofilm virulence and destruction?
2) How can we knock down some of those big players as they barrel down the field making a run for a touchdown?
Understanding the pathogenic load and burden will help guide us to implement a more individualized treatment plan for our clients. This is where our assessment, knowledge and education are critical in our development of an active periodontal therapy treatment that will decrease bleeding, inflammation, and begin shifting the biofilm to a healthier balance. Then we can decide how aggressive we need to be in our strategy, what tools we will employ, and how we will educate our clients with respect to their role in their transition from disease to health.
Our Periodontal Therapy Strategy Must Include The Following:
While reducing the bacterial burden is critical to our success and will ultimately reduce localized bleeding and inflammation, we must also consider chronic systemic inflammation. Could we gain greater ground by also addressing the host response with Subantimicrobial-Dose Doxycycline? (Periostat®)
Finally, we must help our patients to modify as many risk factors as possible which includes their ability to maintain optimal self care on a daily basis. Have we also placed them on the most appropriate hygiene recare interval? Can we add any additional home care strategies such as xylitol products and/or oral probiotics to help further tip the balance towards health? Only when we address all of these points, will we be well on our way to making a difference in our patients oral and overall health.
Thank you Lorraine!
Thank you for reading and have a great week ahead. Please take a look at below for what is coming up!
Kindest regards,
Kathleen